155 related articles for article (PubMed ID: 12839140)
1. Impact of WHI conclusions and ACOG guidelines on clinical practice.
Gass M
Int J Fertil Womens Med; 2003; 48(3):106-10; discussion 137-8. PubMed ID: 12839140
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
Burger H
Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
[TBL] [Abstract][Full Text] [Related]
3. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
Kuhl H; Stevenson J
Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
[TBL] [Abstract][Full Text] [Related]
4. The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program.
Hillman JJ; Zuckerman IH; Lee E
J Womens Health (Larchmt); 2004 Nov; 13(9):986-92. PubMed ID: 15665655
[TBL] [Abstract][Full Text] [Related]
5. [After the early termination of the Women's Health Initiative study. New American recommendations for postmenopausal hormone therapy].
Stjernquist M;
Lakartidningen; 2003 May; 100(20):1790-7. PubMed ID: 12806859
[TBL] [Abstract][Full Text] [Related]
6. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.
Modena MG; Sismondi P; Mueck AO; Kuttenn F; Lignières Bd; Verhaeghe J; Foidart JM; Caufriez A; Genazzani AR;
Maturitas; 2005 Sep; 52(1):1-10. PubMed ID: 15963666
[TBL] [Abstract][Full Text] [Related]
7. Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.
Kang BM; Kim MR; Park HM; Yoon BK; Lee BS; Chung HW; Cho SH; Choi H; Kim JG
Menopause; 2006; 13(1):125-9. PubMed ID: 16607108
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
[TBL] [Abstract][Full Text] [Related]
9. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
Anderson GL; Chlebowski RT; Rossouw JE; Rodabough RJ; McTiernan A; Margolis KL; Aggerwal A; David Curb J; Hendrix SL; Allan Hubbell F; Khandekar J; Lane DS; Lasser N; Lopez AM; Potter J; Ritenbaugh C
Maturitas; 2006 Sep; 55(2):103-15. PubMed ID: 16815651
[TBL] [Abstract][Full Text] [Related]
10. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
Prescrire Int; 2004 Jun; 13(71):106-9. PubMed ID: 15233153
[TBL] [Abstract][Full Text] [Related]
11. A clinician's review of the WHI-related literature.
Speroff L
Int J Fertil Womens Med; 2004; 49(6):252-67. PubMed ID: 15751264
[TBL] [Abstract][Full Text] [Related]
12. Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial.
Shapiro S
Climacteric; 2003 Dec; 6(4):302-10; discussion 310-3. PubMed ID: 15006251
[TBL] [Abstract][Full Text] [Related]
13. Abbreviated hormone replacement therapy trial answers some questions, raises new ones. The Women's Health Initiative is no longer testing the most widely prescribed estrogen and progestin combination--but the study's job is far from over.
Harv Womens Health Watch; 2002 Oct; 10(2):2-4. PubMed ID: 12393317
[No Abstract] [Full Text] [Related]
14. Hormone therapy. A year in review.
Mayo Clin Womens Healthsource; 2003 Aug; 7(8):1-2. PubMed ID: 12925832
[TBL] [Abstract][Full Text] [Related]
15. HRT: forever or never?
Corson SL
Int J Fertil Womens Med; 2002; 47(4):150-1. PubMed ID: 12199410
[No Abstract] [Full Text] [Related]
16. Gynecologists' attitudes towards hormone therapy in the post "Women's Health Initiative" study era.
Nassar AH; Abd Essamad HM; Awwad JT; Khoury NG; Usta IM
Maturitas; 2005 Sep; 52(1):18-25. PubMed ID: 16143222
[TBL] [Abstract][Full Text] [Related]
17. A comparative review of the risks and benefits of hormone replacement therapy regimens.
Warren MP
Am J Obstet Gynecol; 2004 Apr; 190(4):1141-67. PubMed ID: 15118656
[TBL] [Abstract][Full Text] [Related]
18. [Health symptom-free women do not need preventive hormone replacement therapy. The risks outweigh the benefits; a large trial prematurely interrupted in the USA].
von Schoultz B
Lakartidningen; 2002 Aug; 99(34):3276-8. PubMed ID: 12362844
[No Abstract] [Full Text] [Related]
19. WHI clinical trial revisit: imprecise scientific methodology disqualifies the study's outcomes.
Ostrzenski A; Ostrzenska KM
Am J Obstet Gynecol; 2005 Nov; 193(5):1599-604; discussion 1605-6. PubMed ID: 16260198
[TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy in postmenopausal women.
Yasui T; Uemura H; Takikawa M; Irahara M
J Med Invest; 2003 Aug; 50(3-4):136-45. PubMed ID: 13678382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
